hydroxybenzylpindolol has been researched along with wb 4101 in 1 studies
Studies (hydroxybenzylpindolol) | Trials (hydroxybenzylpindolol) | Recent Studies (post-2010) (hydroxybenzylpindolol) | Studies (wb 4101) | Trials (wb 4101) | Recent Studies (post-2010) (wb 4101) |
---|---|---|---|---|---|
30 | 1 | 0 | 477 | 1 | 34 |
Protein | Taxonomy | hydroxybenzylpindolol (IC50) | wb 4101 (IC50) |
---|---|---|---|
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eckelman, WC; Francis, B; Gibson, RE; Grissom, MP; Reba, RC | 1 |
1 other study(ies) available for hydroxybenzylpindolol and wb 4101
Article | Year |
---|---|
The use of tritium labeled compounds to develop gamma-emitting receptor-binding radiotracers.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Dihydroalprenolol; Dioxanes; Dogs; Guinea Pigs; Heart; Humans; Male; N-Methylscopolamine; Parasympatholytics; Pindolol; Prazosin; Propanolamines; Quinuclidinyl Benzilate; Rabbits; Radionuclide Imaging; Rats; Scopolamine Derivatives; Tritium | 1982 |